Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health
- PMID: 29516342
- DOI: 10.1007/s11136-018-1828-1
Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health
Abstract
Background: Anxiety and depression disorders are associated with significantly lower health-related quality of life (HRQL). The EQ-5D is a commonly used generic measure of HRQL; it captures mental health through a single domain-the anxiety/depression dimension. Evidence on the responsiveness of this measure in assessing changes in mental health changes is limited.
Objective: To examine the performance of the anxiety/depression dimension (A/D) of the 3- and 5-level (3L and 5L) versions of the EQ-5D in assessing changes in mental health.
Methods: Data from two patient populations were used: 495 adults post-discharge from general internal medicine ward (EQ-5D-3L), and 225 type 2 diabetes patients who screened positive for depressive symptoms (EQ-5D-5L). Anchor-based approach along with effect sizes (ES) and ROC analysis was used. Anchors included patient health questionnaire 9-items "PHQ9" and generalized anxiety disorder 2-item questionnaire "GAD2" for EQ-5D-3L, and PHQ9 and SF-12 mental composite summary scores (MCS) for EQ-5D-5L. A/D change was quantified as the difference between follow-up and baseline levels.
Results: The A/D dimension of the EQ-5D-3L showed limited responsiveness to changes in depressive symptoms measured by PHQ9 and for anxiety symptoms measured by GAD2, whereby in those who improved or deteriorated in either symptom, more than half of the patients did not have an A/D change. In the ROC analysis, the A/D dimension of the EQ-5D-3L showed weak performance with C-indices ranging from 0.58 to 0.63 and probability of detection of depressive or anxiety symptoms ranging between 20 and 40%, which are all well below acceptable ranges. Similar results were observed for the A/D dimension of the EQ-5D-5L; although the performance was slightly better, it was still below acceptable range. In patients who improved or deteriorated based on the PHQ9 or MCS, around a third had no changes on the A/D dimension. The performance of the A/D dimension of the EQ-5D-5L was also very limited with C-indices ranging between 0.67 and 0.76, and probability of detection between 50 and 67%, slightly better than that of the 3L, yet unsatisfactory.
Conclusions: Although the A/D of both EQ-5D-3L and 5L was limited in capturing changes in mental health in these populations, the 5L was slightly more responsive than the 3L. While the performance was better for depressive than anxiety symptoms, it varied by the direction of change. Further research using other measures of mental health in other populations is warranted.
Keywords: Anxiety; Depression; EQ-5D; Mental health; Responsiveness.
Similar articles
-
The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.Clin Orthop Relat Res. 2019 Jul;477(7):1632-1644. doi: 10.1097/CORR.0000000000000662. Clin Orthop Relat Res. 2019. PMID: 30801280 Free PMC article.
-
Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.Arch Dermatol Res. 2017 Jul;309(5):357-370. doi: 10.1007/s00403-017-1743-2. Epub 2017 May 20. Arch Dermatol Res. 2017. PMID: 28528371
-
The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings.Health Qual Life Outcomes. 2021 Mar 19;19(1):96. doi: 10.1186/s12955-021-01731-x. Health Qual Life Outcomes. 2021. PMID: 33741011 Free PMC article.
-
Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan.Arch Gerontol Geriatr. 2018 Sep-Oct;78:96-100. doi: 10.1016/j.archger.2018.06.006. Epub 2018 Jun 18. Arch Gerontol Geriatr. 2018. PMID: 29936330 Review.
-
Head-to-Head Comparisons of the Distributional Characteristics and Measurement Properties of the 3-Level and 5-Level Versions of the EQ-5D-Y: A Systematic Review.Value Health. 2025 Apr 15:S1098-3015(25)02303-4. doi: 10.1016/j.jval.2025.03.020. Online ahead of print. Value Health. 2025. PMID: 40246069 Review.
Cited by
-
Assessing the validity and responsiveness of a generic preference quality of life measure in the context of posttraumatic stress disorder.Qual Life Res. 2023 Oct;32(10):2817-2827. doi: 10.1007/s11136-023-03432-y. Epub 2023 May 14. Qual Life Res. 2023. PMID: 37179519 Free PMC article.
-
Psychometric properties of the EQ-5D-5L: a systematic review of the literature.Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7. Qual Life Res. 2021. PMID: 33284428 Free PMC article.
-
Health-related quality of life in different trimesters during pregnancy.Health Qual Life Outcomes. 2021 Jul 21;19(1):182. doi: 10.1186/s12955-021-01811-y. Health Qual Life Outcomes. 2021. PMID: 34289867 Free PMC article.
-
Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings.Psychiatry Clin Neurosci. 2021 Nov;75(11):341-350. doi: 10.1111/pcn.13298. Epub 2021 Sep 17. Psychiatry Clin Neurosci. 2021. PMID: 34459077 Free PMC article. Clinical Trial.
-
Patient-Reported Anxiety/Depression After Endovascular Thrombectomy: A post-hoc Analysis of Direct-MT Trial.Front Neurol. 2022 Feb 9;13:811629. doi: 10.3389/fneur.2022.811629. eCollection 2022. Front Neurol. 2022. PMID: 35222248 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical